Skip to content
Lower risk Medical device recall · FDA · Published February 13, 2025

Remel Blood Agar Biplate Recall: Listeria Contamination Risk

Remel recalls 100 units of Blood Agar Biplate (Ref R02041) for potential Listeria monocytogenes contamination in diagnostic use. Affected units may show visible contamination on the blood side.

🇺🇸 FDA recall #Z-1201-2025Medical deviceRemel ›
Take action

Contact the company

Recalling firmRemel, Inc12076 Santa Fe Trail Dr · Lenexa, KS 66215-3519
✎ GovInfoNow plain-language explainer

Remel is recalling 100 Blood Agar Biplate units (Ref R02041) for possible Listeria monocytogenes contamination. This could lead to infections if used in diagnostic testing. Read more at govinfonow.com/recall/52861-remel-blood-agar-biplate-recall-listeria-contamination-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/52861-remel-blood-agar-biplate-recall-listeria-contamination-risk · Updated August 18, 2026 · FDA enforcement record: FDA #Z-1201-2025

Cite this page

“Remel Blood Agar Biplate Recall: Listeria Contamination Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/52861-remel-blood-agar-biplate-recall-listeria-contamination-risk. Based on FDA recall #Z-1201-2025 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1201-2025%22&limit=1).

The FDA announced on Feb. 13, 2025, that Remel, Inc. is recalling remel BLOOD AGAR EMB AGAR BIPLATE due to potential Listeria monocytogenes contamination. Owners should stop using the product immediately.

How to tell if you have it

  • Brand: Remel
  • Product: remel BLOOD AGAR EMB AGAR BIPLATE, REF R02041, QTY 100
  • Lot Number: 213971
  • Expiration Date: 2025-02-25
  • Units Affected: 316

The hazard

The product may contain surface and subsurface contamination of Listeria monocytogenes, which is typically visible immediately upon removal from the packaging on the blood side of the biplate.

Context

GovInfoNow's records show Remel, Inc. has issued 22 other recalls since Nov. 2, 2017. Recent similar recalls include a June 3, 2026, recall for reduced Neisseria gonorrhoeae recovery risk and a March 24, 2026, recall for incorrect lab results risk. Other recent recalls of similar products include a Dec. 24, 2025, Medline Blood Culture Kit recall and a June 12, 2026, Medline Convenience Kits recall.

How to tell if you have this one

Check for the product name 'Blood Agar Biplate', reference number R02041, and lot number 213971. The expiration date is February 25, 2025.

  • Brand
    Remel
  • Category
    Medical device
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    US Nationwide distribution.
Recall numberProduct, codes & lotsQuantity
Z-1200-2025remel BLOOD AGAR MacCONKEY AGAR BIPLATE, REF R02049, QTY 100, for invitro diagnostic use; UDI/DI 848838003691, Lot Number 213926, exp. 2025-02-24787 units
Z-1201-2025remel BLOOD AGAR EMB AGAR BIPLATE, REF R02041, QTY 100, for invitro diagnostic use; UDI/DI 848838003684, Lot Number 213971, exp. 2025-02-25316 units
Based on the official FDA remedy

What to do — step by step

  1. Check for Contamination

    Inspect the blood side of the biplate for visible Listeria contamination after removing it from packaging.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “US Nationwide distribution.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 13 days after the firm started it.

1. Firm started the recall: Feb 13, 202512. FDA classified it Class II: Feb 20, 202523. Published in FDA’s Enforcement Report: Feb 26, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1201-2025 (February 13, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1201-2025 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA